Home LiteratureArticle Details
PMID: 10235536 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP.

Investigative ophthalmology & visual science ·Vol. 40 ·No. 6 ·1999-05-00 ·Pages 1033-9

Ghiso N, Rohan RM, Amano S, Garland R, Adamis AP

Abstract

To investigate the suppressive effect of nitric oxide (NO) on vascular endothelial growth factor (VEGF) gene expression and to elucidate its mechanism of action. Immortalized human retinal epithelial (RPE) cells, H-ras-transfected murine capillary endothelial cells, and nuclear factor-kappaB (NF-kappaB) RelA knockout 3T3 fibroblasts had VEGF gene expression stimulated by hypoxia, TPA (phorbol ester 12-O-tetradecanoylphorbol-13 acetate), and ras-transfection. The dose response and time course of inhibition of VEGF gene expression by NO were characterized by northern blot analysis, ribonuclease protection assay, and enzyme-linked immunosorbent assay. The effects of NF-kappaB and cGMP in the NO-induced suppression of VEGF gene expression were quantitated. cGMP production was inhibited by LY 83583 (6-anilino-5,8-quinolinedione), a specific inhibitor of guanylate cyclase production, and cGMP accumulation was quantitated by immunoassay. RelA knockout 3T3 fibroblasts were used to assess the contribution of NF-kappaB to the downregulation of VEGF by NO. The NO donor sodium nitroprusside (SNP) decreased hypoxia-induced VEGF gene expression in a dose- and time-dependent manner. One hundred fifty micromolar SNP completely suppressed hypoxia-induced VEGF mRNA levels for at least 24 hours. Constitutive VEGF expression was not altered by SNP. The SNP-mediated decreases in VEGF expression were associated with increases in intracellular cGMP and were blocked by LY 83583. Sodium nitroprusside was able to decrease hypoxia-induced VEGF mRNA increases in fibroblasts deficient in the RelA subunit of NF-kappaB. Nitric oxide was also effective at suppressing increased VEGF expression secondan, to mutant ras and TPA. These data indicate that NO decreases hypoxia-induced VEGF via a cGMP-dependent mechanism and suggest that NO may serve as an endogenous inhibitor of both hypoxia- and non- hypoxia-enhanced VEGF expression in vivo.

MeSH Terms
3T3 Cells Animals Cell Line Cyclic CMP/physiology Endothelial Growth Factors/antagonists & inhibitors,genetics Endothelium, Vascular/cytology,physiology Gene Expression/drug effects,physiology Genes, ras/genetics Humans Hypoxia/genetics Lymphokines/antagonists & inhibitors,genetics Mice NF-kappa B/physiology Nitric Oxide/physiology Nitric Oxide Donors/pharmacology Nitroprusside/pharmacology Retina/cytology,physiology Tetradecanoylphorbol Acetate/pharmacology Time Factors Transfection Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Lymphokines NF-kappa B Nitric Oxide Donors Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Nitroprusside Nitric Oxide Cyclic CMP Tetradecanoylphorbol Acetate
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ghiso N
Department of Surgery, Children's Hospital, Boston, Massachusetts, USA.
Rohan R M
Amano S
Garland R
Adamis A P
Article Info
Journal
Investigative ophthalmology & visual science
Abbr.
Invest Ophthalmol Vis Sci
ISSN
0146-0404
Published
1999-05-00
Pages
1033-9
Language
English
Region
United States
NLM ID
7703701
Subset
IM
Grants
NEI NIH HHS · EY 11622 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]